Margarita Y. Timofeeva

Moscow, MOW, RU 
Clinical Trials:Currently Recruiting for 1 Trial
Moscow, MOW, RU 

Overview

Margarita Timofeeva practices practicing medicine in Moscow, Russian Federation.

Her clinical expertise encompasses Hemophilia B, Von Willebrand Disease (VWD), Blood Clots, and Hemophilia A.

She is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Moscow, MOW 119991, Russian Federation
Other Locations
Kirov, KIR, Russian Federation

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Prospective, Multicenter, Uncontrolled, Open-Label Clinical Study to Determine the Efficacy, Safety, and Tolerability of rVWF With or Without ADVATE in the Treatment and Control of Bleeding Episodes, the Efficacy and Safety of rVWF in Elective and Emergency Surgeries, and the Pharmacokinetics (PK) of rVWF in Children Diagnosed With Severe Von Willebrand Disease
A Phase 3, Prospective, Multicenter, Uncontrolled, Open-Label Clinical Study to Determine the Efficacy, Safety, and Tolerability of rVWF With or Without ADVATE in the Treatment and Control of Bleeding Episodes, the Efficacy and Safety of rVWF in Elective and Emergency Surgeries, and the Pharmacokinetics (PK) of rVWF in Children Diagnosed With Severe Von Willebrand Disease
Enrollment Status: Recruiting
Publish Date: April 30, 2025
Intervention Type: Biological
Study Drugs: Von Willebrand Factor, Factor VIII
Study Phase: Phase 3
A Phase 3b, Prospective, Open-Label, Uncontrolled, Multicenter Study on Long-Term Safety and Efficacy of rVWF in Pediatric and Adult Subjects With Severe Von Willebrand Disease (VWD)
A Phase 3b, Prospective, Open-Label, Uncontrolled, Multicenter Study on Long-Term Safety and Efficacy of rVWF in Pediatric and Adult Subjects With Severe Von Willebrand Disease (VWD)
Enrollment Status: Completed
Publish Date: September 03, 2025
Intervention Type: Biological
Study Drugs: Von Willebrand Factor, Factor VIII
Study Phase: Phase 3
A Phase 3, Multicenter, Open-label Study of the Efficacy and Safety of B-Domain Deleted Recombinant Porcine Factor VIII (BAX 802) in Subjects With Congenital Hemophilia A With Factor VIII Inhibitors Undergoing Surgical or Other Invasive Procedures
A Phase 3, Multicenter, Open-label Study of the Efficacy and Safety of B-Domain Deleted Recombinant Porcine Factor VIII (BAX 802) in Subjects With Congenital Hemophilia A With Factor VIII Inhibitors Undergoing Surgical or Other Invasive Procedures
Enrollment Status: Terminated
Publish Date: October 20, 2021
Intervention Type: Biological
Study Phase: Phase 3
View 2 Less Clinical Trial

9 Total Publications

THE COMPARATIVE ANALYSIS OF ASPECTS OF DEFENSE OF REPUTATION OF MEDICAL ORGANIZATION AND ITS PERSONNEL IN THE RUSSIAN FEDERATION AND CERTAIN FOREIGN COUNTRIES
THE COMPARATIVE ANALYSIS OF ASPECTS OF DEFENSE OF REPUTATION OF MEDICAL ORGANIZATION AND ITS PERSONNEL IN THE RUSSIAN FEDERATION AND CERTAIN FOREIGN COUNTRIES
Journal: Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny
Published: September 29, 2025

Frequently Asked Questions about Margarita Y. Timofeeva

Is Margarita Y. Timofeeva a top-rated expert for Hemophilia B?

MediFind is an objective health platform that identifies experts based on real-world data. Margarita Y. Timofeeva is classified as an Experienced expert for Hemophilia B, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Margarita Y. Timofeeva participate in research or clinical trials?

Yes. Margarita Y. Timofeeva has published 9 articles and abstracts on conditions like Hemophilia B. You can view a list of Margarita Y. Timofeeva's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Timofeeva's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile